公开(公告)号：KR1020130009084A

公开(公告)日：2013-01-23

申请号：KR1020110069920

申请日：2011-07-14

Applicant: 덕성여자대학교 산학협력단

Inventor： 문애리 ,  송재인 ,  강유진 ,  용해영 ,  김영중

IPC: A61K36/8984 ,  A61K31/015 ,  A61P35/00

CPC classification number: A61K31/122 ,  A61K36/8984

Abstract: PURPOSE: A pharmaceutical composition containing a Dendrobium moniliforme extract and denbinobin for anti-gastric cancer is provided to suppress expression of S100A8 protein and reduce infiltration. CONSTITUTION: A pharmaceutical composition for anti-gastric cancer contains a Dendrobium moniliforme extract and a pharmaceutically acceptable salt as an active ingredient. The pharmaceutical composition for anti-gastric cancer contains denbinobin and a pharmaceutically acceptable carrier as an active ingredient. The therapeutically effective amount of denbinobin is 0.01-25%. Denbinobin is extracted from Dendrobium moniliforme or chemically synthesized. The pharmaceutical composition is used by oral administration or parenteral administration.

Abstract translation: 目的：提供含有石斛龙骨提取物和丹参素用于抗胃癌的药物组合物，以抑制S100A8蛋白的表达并减少浸润。 构成：用于抗胃癌的药物组合物含有石斛提取物和药学上可接受的盐作为活性成分。 用于抗胃癌的药物组合物含有丹参蛋白和药学上可接受的载体作为活性成分。 丹参素的治疗有效量为0.01〜25％。 丹参素从石斛石斛提取或化学合成。 药物组合物通过口服给药或肠胃外给药使用。